FDA Approves CVD Benefit for Once-Weekly Semaglutide FDA Approves CVD Benefit for Once-Weekly Semaglutide

Information regarding cardiovascular safety was also added to the label of the daily oral semaglutide formulation.FDA Approvals
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Diabetes & Endocrinology News Alert Source Type: news